ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation

Xu, Qiang; Xu, Bin; Zhang, Yuxiao; Yang, Jie; Gao, Lei; Zhang, Yan; Wang, Hongjuan; Lu, Caiyi; Zhao, Yusheng; Yin, Tong*gen hosp peoples liberat army
Thrombosis and Haemostasis2012-12DOI: 10.1160/TH12-05-0362
17被引10阅读
引用收藏
分享

摘要

Pharmacogenetic (PG) dosing algorithms have been confirmed to predict warfarin therapeutic dose more accurately; however, most of them are based on standard intensity of warfarin anticoagulation, and their utility outside this range is limited. This study was designed to develop and validate a PG refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation. Consented Chinese-Han patients (n=310) under stable warfarin treatment were randomly divided into a derivation (n=207) and a validation cohort (n=103), with 83% and 80% of the patients under low-intensity anticoagulation, respectively. In the derivation cohort, a PG algorithm was constructed on the basis of genotypes (CYP2C9*3 and VKORC1-1639A/G) and clinical data. After integrating additional covariates of international normalised ratio (INR) values (INR on day 4 of therapy and target INR) and genotype of CYP4F2 (rs2108622), a PG refinement algorithm was established and explained 54% of warfarin dose variability. In the validation cohort, warfarin dose prediction was more accurate (p < 0.01) with the PG refinement algorithm than with the PG algorithm and the fixed dose approach (3 mg/day). In the entire cohort, the PG refinement algorithm could accurately identify larger proportions of patients with lower dose requirement (<= 2 mg/day) and higher dose requirement (<= 4 mg/day) than did the PG algorithm. In conclusion, PG refinement algorithm integrating early INR response and three genotypes (CYP2C9*3, VKORC1-1639A/G, CYP4F2 rs2108622) improves the accuracy of warfarin dose prediction in Chinese patients mainly under low-intensity anticoagulation.

学科与关键词

关键词
Warfarinpharmacogeneticsdosing algorithmlow-intensity anti-coagulation
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Thrombosis and Haemostasis
发表日期
2012-12
卷期
第 108 卷, 第 6 期
页码
1132-1140
DOI
10.1160/TH12-05-0362
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [30971259]; General Hospital of Chinese People's Liberation Army [09KMM23]

作者

  • X

    Xu, Qiang (第一作者)

    gen hosp peoples liberat army

  • X

    Xu, Bin

    gen hosp peoples liberat army

查看全部 10 位作者收起作者
  • Z

    Zhang, Yuxiao

  • Y

    Yang, Jie

    gen hosp peoples liberat army

  • G

    Gao, Lei

    gen hosp peoples liberat army

  • Z

    Zhang, Yan

  • W

    Wang, Hongjuan

    gen hosp peoples liberat army

  • L

    Lu, Caiyi

    gen hosp peoples liberat army

  • Z

    Zhao, Yusheng

    gen hosp peoples liberat army

  • Y

    Yin, Tong (通讯)

    gen hosp peoples liberat army

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417